Answer
Beta-blockers may weaken or oppose Enerzair Breezhaler’s beta2-agonist effect, so concurrent use should be avoided unless compelling reasons exist, with cardioselective beta-blockers preferred and used cautiously if required.
Sources for this answer
- Enerzair BreezhalerNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 7Document updated
Sources checked